More than 150,000 people in the UK have MS, a devastating chronic immune disease that can cause problems with sight, writing, ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

With the ICSE 2025 exams right around the corner, let’s take a look at the ICSE Class 10 Biology paper. Preparing for the ...

Jefferies analyst Matthew Taylor revised the stock rating for Nevro Corp (NYSE:NVRO), elevating it from Underperform to Hold. Accompanying this upgrade, the price target also saw an increase to $5.85, ...

When France began its first large-scale experiment with medical marijuana, the expectation was that it could lead to ...